McClanahan, F., Hielscher, T., Neben, K., Hillengaß, J., Krämer, A., Ho, A. D., & Witzens-Harig, M. (2012). Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. American journal of hematology, 87(10), . https://doi.org/10.1002/ajh.23286
Chicago-Zitierstil (17. Ausg.)McClanahan, Fabienne, Thomas Hielscher, Kai Neben, Jens Hillengaß, Alwin Krämer, Anthony Dick Ho, und Mathias Witzens-Harig. "Final Results of a Randomized Trial Comparing 1, 3, or 6 Infusions of Rituximab Plus 6 Cycles CHOP Provide Valuable Preliminary Data Towards a More Cost-effective and Safer Treatment of Advanced Follicular Lymphoma." American Journal of Hematology 87, no. 10 (2012). https://doi.org/10.1002/ajh.23286.
MLA-Zitierstil (9. Ausg.)McClanahan, Fabienne, et al. "Final Results of a Randomized Trial Comparing 1, 3, or 6 Infusions of Rituximab Plus 6 Cycles CHOP Provide Valuable Preliminary Data Towards a More Cost-effective and Safer Treatment of Advanced Follicular Lymphoma." American Journal of Hematology, vol. 87, no. 10, 2012, https://doi.org/10.1002/ajh.23286.